$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
奥普杜拉格(Opdualag)的用法用量:推荐剂量、剂量调整
2025-10-19 11:44:20
Check Details
奥普杜拉格(Opdualag)的中文说明书
2025-10-19 11:44:20
Check Details
奥普杜拉格(Opdualag)的详细说明书:适应症、用法用量、副作用及注意事项等
2025-10-19 11:44:20
Check Details
FDA批准康奈非尼(Encorafenib)与比美替尼(Binimetinib)联合用于治疗携带BRAF突变的不可切除或转移性黑色素瘤
2025-10-19 11:44:20
Check Details
FDA批准康奈非尼联合比美替尼用于携带BRAFV600E突变的转移性非小细胞肺癌
2025-10-19 11:44:20
Check Details
比美替尼(Binimetinib)的副作用和不良反应
2025-10-19 11:44:20
Check Details
比美替尼(Binimetinib)的中文说明书
2025-10-19 11:44:20
Check Details
比美替尼(Binimetinib)的用法用量:常用剂量、剂量调整
2025-10-19 11:44:20
Check Details
比美替尼(Binimetinib)的详细说明书:适应症、用法用量、副作用及注意事项等
2025-10-19 11:44:20
Check Details
伊匹木单抗的副作用如何缓解
2025-10-19 11:44:20
Check Details
伊匹木单抗副作用与注意事项
2025-10-19 11:44:20
Check Details
伊匹木单抗的用药指南
2025-10-19 11:44:20
Check Details
1
2
...
6805
6806
6807
6808
6809
6810
6811
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Sparsentan Drug Interactions: Hypotension, Hyperkalemia, Renal Risk, CYP3A
2
How to Take Vigabatrin: Dosing and Vision Monitoring
3
Who Makes Belzutifan: Welireg and Merck/ MSD Explained
4
FDA Approves Infilbray for GD3 Neurological Symptoms
5
How to Take Selinexor: Dosing, Food, and Safety
6
FDA Approves Nelkarmi for ALK-TKI-Resistant NSCLC
7
FDA Approves Lembaz: First Therapy Shown to Extend Survival in Infantile-Onset NPC
8
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
9
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
10
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
11
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
12
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring